Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Adriana Estrada-Bernal
ALK Is a Critical Regulator of the MYC-signaling Axis in ALK Positive Lung Cancer
Oncotarget
Oncology
Related publications
Development of Anaplastic Lymphoma Kinase (ALK) Inhibitors and Molecular Diagnosis in ALK Rearrangement-Positive Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Outcomes of ALK Positive Lung Cancer Patients Treated With Crizotinib or Second-Generation ALK Inhibitor: A Monoinstitutional Experience
Oncotarget
Oncology
P1.02-05 ALK Positive Lung Cancer: Patient Engagement and Partnership
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Overcoming Drug-Tolerant Cancer Cell Subpopulations Showing AXL Activation and Epithelial–mesenchymal Transition Is Critical in Conquering ALK-positive Lung Cancer
Oncotarget
Oncology
175P: ALK Positive Lung Cancer: Clinical Profile and Outcomes in a Developing Country
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-89 Synergistic Cytotoxicity Through MAPK/ERK Pathway and ALK Inhibition in Crizotinib Resistant EML4-ALK-Positive Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P087 TNM Staging Inversely Correlates With Age in ALK-positive Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
